Summary & Overview
CPT 93580: Transcatheter Atrial Septal Defect Closure
CPT code 93580 represents a percutaneous transcatheter atrial septal defect (ASD) closure procedure in which an implant is delivered via catheter to seal an opening in the atrial septum. Nationally, this code captures an important, minimally invasive alternative to open surgical repair for congenital or iatrogenic atrial septal communications and is relevant for cardiac interventionalists, hospitals, and payers managing complex cardiovascular care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and the common modifiers that may accompany claims. The publication also highlights benchmarking elements commonly reviewed by payers and providers (procedure utilization, site-of-service patterns, and coding nuances) and notes where input data is not provided.
This summary provides the groundwork to understand billing and administrative considerations tied to CPT code 93580, situating the code within cardiovascular service lines and hospital-based interventional care. Data not available in the input is flagged where relevant.
Billing Code Overview
CPT code 93580 describes a percutaneous transcatheter procedure to close an opening in the atrial septum (an atrial septal defect or surgically created opening). The provider advances a catheter through a large vein in the groin into the right side of the heart, injects contrast dye, obtains imaging of the atrial chambers and ventricles, and deploys an implant to occlude the septal defect.
-
Service type: Percutaneous transcatheter atrial septal defect closure
-
Typical site of service: Hospital catheterization laboratory or specialized cardiac interventional suite
Clinical & Coding Specifications
Clinical Context
A 7-year-old child with a history of exertional dyspnea and recurrent right-sided cardiac murmurs is referred for transcatheter closure of an atrial septal defect (ASD). Prior transthoracic echocardiography documents a secundum-type ASD with right atrial and right ventricular enlargement. The interventional cardiology team schedules a catheter-based procedure under general anesthesia in a cardiac catheterization laboratory. A femoral venous access is obtained, a catheter is advanced to the right atrium, and contrast angiography and transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) are used to define the defect size and rims. Hemodynamic measurements and imaging guide selection and deployment of a septal occluder device. Post-deployment angiography and echocardiography confirm device position and absence of residual shunt or obstruction. The patient is monitored in a post-anesthesia care area and typically discharged same day or after an overnight observation with instructions for activity restriction and endocarditis prophylaxis guidance as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician interpretation/management component separate from technical services (rare for this code). |
52 |